Table 3. Spearman correlation.
Type of data | Feature studied | PC1 | TCMR | QCAT | GRIT1 | QCMAT | IRRAT | KT1 | CT1 |
---|---|---|---|---|---|---|---|---|---|
Clinical and endoscopic | Mayo Score at biopsy site | 0.74a | 0.59a | 0.56a | 0.70a | 0.55a | 0.72a | -0.57a | -0.73a |
Endoscopic Mayo Score | 0.70a | 0.54a | 0.55a | 0.68a | 0.49b | 0.69a | -0.55a | -0.70a | |
Total Mayo Score | 0.70a | 0.56a | 0.57a | 0.72a | 0.49a | 0.60a | -0.55a | -0.67a | |
Disease extent | 0.68a | 0.71a | 0.67a | 0.69a | 0.44 | 0.58a | -0.58a | -0.60a | |
Physicians' Global Assessment | 0.65a | 0.43b | 0.45 | 0.58a | 0.41b | 0.67a | -0.50b | -0.67a | |
Stool frequency | 0.61a | 0.47b | 0.59a | 0.64a | 0.40b | 0.50a | -0.40b | -0.53a | |
Rectal Bleeding | 0.35 | 0.29 | 0.36 | 0.43b | 0.35 | 0.22 | -0.26 | -0.32 | |
Pseudopolyps | -0.20 | -0.25 | -0.22 | -0.11 | -0.08 | -0.13 | 0.16 | 0.12 | |
Age at biopsy | -0.46 | -0.35 | -0.36 | -0.39b | -0.44b | -0.41b | 0.39 | 0.46 | |
Disease duration | -0.58a | -0.56a | -0.56a | -0.45b | -0.39 | -0.51a | 0.42b | 0.53a | |
Albumin | -0.67a | -0.53a | -0.57a | -0.65a | -0.69a | -0.58a | 0.54a | 0.62a | |
Histology | Lamina propria lymphoplasmacytic infiltrate | 0.81a | 0.82a | 0.78a | 0.72a | 0.47 | 0.69a | -0.79a | -0.80a |
Lamina propria neutrophils | 0.59a | 0.52a | 0.56a | 0.57a | 0.43b | 0.49b | -0.46b | -0.52a | |
Intra epithelial neutrophils | 0.44 | 0.46b | 0.54a | 0.40b | 0.26 | 0.33 | -0.40b | -0.37 | |
Crypt absesses | 0.40 | 0.40b | 0.44b | 0.40b | 0.27 | 0.38 | -0.40b | -0.42 | |
Branched crypts | 0.30 | 0.30 | 0.26 | 0.14 | 0.03 | 0.32 | -0.25 | -0.33 | |
Biopsy pieces assessed in location | 0.08 | 0.05 | 0.02 | 0.05 | 0.27 | 0.11 | -0.07 | -0.11 |
P value<0.01;
P value<0.05
Bold indicates highest correlations within each type of data.